Lawmakers, Health Orgs Advocate Clinical Trial Diversity Steps

Lawmakers have introduced a new bill offering solutions to reduce the financial obstacles to diverse clinical trial participation, while FDA and other agencies undertake multiple initiatives to boost trial diversity -- but FDA’s commissioner acknowledged there are difficult obstacles to overcome in a system not set up for equitable access to care. Rep. Raul Ruiz (D-CA) and Rep. Larry Bucshon (R-IN) recently introduced the Clinical Trial Modernization Act that would incentivize trial diversity in a number of ways, including allowing...